Ella 30mg (Ulipristal Acetate Tablet) 30mg

Ella 30mg is used as an emergency contraceptive to prevent pregnancy after unprotected intercourse or contraceptive failure. It works by delaying or inhibiting ovulation, thereby preventing fertilization. Here are the key indications:

• Emergency contraception: Prevents pregnancy when taken within 120 hours (5 days) after unprotected intercourse or known or suspected contraceptive failure. It is not intended for routine use as a contraceptive. It is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. Ella is not intended for routine use as a contraceptive. ( 1 )

• Ulipristal acetate works by binding to progesterone receptors, acting as a selective progesterone receptor modulator. It delays or inhibits ovulation by altering the hormonal environment necessary for the release of an egg from the ovary. This mechanism prevents fertilization and thus pregnancy. It is a synthetic compound that affects the endometrial tissue and the menstrual cycle, providing a temporary contraceptive effect.

Ella 30mg may cause various side effects, ranging from common to serious. Common Side Effects:

• Nausea: Mild to moderate nausea may occur after taking the medication.
• Headache: Some users may experience headaches.
• Abdominal pain: Discomfort or pain in the abdominal area is possible.
• Fatigue: Feeling tired or weak may be a side effect.
• Dizziness: Some individuals may feel dizzy after taking the medication.

Serious or Rare Side Effects

• Allergic reactions: Rare but possible, including rash, itching, or swelling.
• Severe abdominal pain: Persistent or severe pain should be evaluated by a healthcare professional.
• Vomiting: If vomiting occurs within 3 hours of taking the medication, the dose may need to be repeated.
• Menstrual irregularities: Changes in menstrual bleeding patterns may occur.

Ella 30mg should be used with caution and under the guidance of a healthcare professional. Important precautions include:

• Allergies: Inform your healthcare provider if you have any known allergies to ulipristal acetate or any other ingredients in the medication.
• Pregnancy: Ella 30mg should not be used if pregnancy is already suspected or confirmed.
• Breastfeeding: Consult your healthcare provider before using Ella 30mg while breastfeeding.
• Liver disease: Inform your healthcare provider if you have liver problems, as this may affect the use of the medication.
• Drug interactions: Inform your healthcare provider about all medications you are taking to avoid potential interactions.
• Store below 25°C: Keep in the original pack, protect from moisture.

Ella 30mg may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major Interactions (Avoid):

• CYP3A4 inducers: Medications that induce the CYP3A4 enzyme, such as rifampin, may reduce the effectiveness of ulipristal acetate.
• Hormonal contraceptives: The use of hormonal contraceptives should be initiated or resumed no sooner than after the next menstrual period following the use of Ella 30mg.

Moderate Interactions (Monitor Closely)

• Antiepileptic drugs: Some antiepileptic medications may affect the metabolism of ulipristal acetate, requiring close monitoring.
• Antifungal medications: Certain antifungal drugs may interact with ulipristal acetate, necessitating careful monitoring.
• HIV protease inhibitors: These medications may affect the metabolism of ulipristal acetate, requiring close monitoring.